Keros is a biopharmaceutical company focused on treatments for rare muscle diseases. Its lead program is a small molecule for the treatment of FOP, an ultra-rare skeletal disease.

biopharmaceuticals
Public (NYSE:KROS)
Visit Website

https://www.kerostx.com/

Additional Portfolio Companies
Abcuro
Adicet Bio
AgomAb Therapeutics
Allena Pharmaceuticals
ArQule
Cathworks
cCAM Biotherapeutics
CheckCap
CytoReason
Dynacure
Eloxx Pharmaceuticals
Enlivex Therapeutics
Eyevensys
EyeYon
ForSight Vision6 (“V6”)
Genocea
Horama
IMEL Biotherapeutics
Immunic Therapeutics
Kamari Pharma
Keros Therapeutics
Kite Pharma
Levation Pharma
LogicBio Therapeutics
Lutris Pharma
Mereo BioPharma
Metabomed
NovellusDX
Ocon Medical
Opiant
PACT Pharma
Pi Therapeutics
Prevail Therapeutics
Precirix (Formerly Camel-IDS)
ProQR
Protalix
Raziel Therapeutics
ReWalk
Saniona
SilverBack Therapeutics
Soligenix
Stargazer Pharmaceuticals
VBI Vaccines
Step Pharma
StimatixGI
Sweetch
TargEDys
Vascular Graft Solutions
UroGen
V-Wave
June 25, 2017